Clinical practice View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-08-26

AUTHORS

Johanna Scheiring, Alejandra Rosales, Lothar Bernd Zimmerhackl

ABSTRACT

The haemolytic uraemic syndrome (HUS) includes the triad of haemolytic anaemia, thrombocytopenia, and acute renal failure. The classical form [D(+) HUS] is caused by infectious agents, and it is a common cause of acute renal failure in children. The enterohaemorrhagic Escherichia coli-producing Shiga toxin (Stx) is the most common infectious agent causing HUS. Other infectious agents are Shigella and Streptococcus pneumoniae. Infections by S. pneumoniae can be particularly severe and has a higher acute mortality and a higher long-term morbidity compared to HUS by Stx. Atypical HUS [D(−)Stx(−)HUS] are often used by paediatricians to indicate a presentation of HUS without preceding diarrhoea. Almost all patients with D(−)Stx(−)HUS have a defect in the alternative pathway, for example, mutations in the genes for complement factor H, factor I, and membrane co-factor protein. Mutations in the factor H gene are described more often. The majority of children with D(+) HUS develop some degree of renal insufficiency, and approximately two thirds of children with HUS will require dialysis therapy, while about one third will have milder renal involvement without the need for dialysis therapy. General management of acute renal failure includes appropriate fluid and electrolyte management, antihypertensive therapy, and the initiation of renal replacement therapy when appropriate. Specific management issues in HUS include management of the haematological complications of HUS, monitoring for extra-renal involvement, avoiding antidiarrhoeal drugs, and possibly avoiding of antibiotic therapy. In addition to the obligatory supportive treatment and tight control of hypertension, there is anecdotal evidence that plasma therapy may induce remission and, in some cases, maintain it. Fresh frozen plasma contains factor H at physiological concentrations. A new therapy for D(−)Stx(−)HUS is a humanised monoclonal antibody (Eculizumab) that blocks complement activity by cleavage of the complement protein C5. It prevents the generation of the inflammatory peptide C5a and the cytotoxic membrane–attack complex C5b-9. We have first positive results, but it is still not approved for HUS. More... »

PAGES

7-13

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00431-009-1039-4

DOI

http://dx.doi.org/10.1007/s00431-009-1039-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1046286380

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19707787


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Kidney Injury", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Complement System Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemolytic-Uremic Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Renal Replacement Therapy", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Paediatrics, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria", 
          "id": "http://www.grid.ac/institutes/grid.5361.1", 
          "name": [
            "Department of Paediatrics, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scheiring", 
        "givenName": "Johanna", 
        "id": "sg:person.01060501551.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060501551.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Paediatrics, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria", 
          "id": "http://www.grid.ac/institutes/grid.5361.1", 
          "name": [
            "Department of Paediatrics, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rosales", 
        "givenName": "Alejandra", 
        "id": "sg:person.01005340007.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005340007.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Paediatrics, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria", 
          "id": "http://www.grid.ac/institutes/grid.5361.1", 
          "name": [
            "Department of Paediatrics, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zimmerhackl", 
        "givenName": "Lothar Bernd", 
        "id": "sg:person.0672444171.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672444171.34"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s004670100564", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040633100", 
          "https://doi.org/10.1007/s004670100564"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00467-008-0964-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034552033", 
          "https://doi.org/10.1007/s00467-008-0964-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00467-004-1451-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049444325", 
          "https://doi.org/10.1007/s00467-004-1451-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s150100050040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045126273", 
          "https://doi.org/10.1007/s150100050040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004670050018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000327276", 
          "https://doi.org/10.1007/s004670050018"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00467-006-0210-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009821667", 
          "https://doi.org/10.1007/s00467-006-0210-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00467-008-0935-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053074373", 
          "https://doi.org/10.1007/s00467-008-0935-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00467-003-1382-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050782066", 
          "https://doi.org/10.1007/s00467-003-1382-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1011921122595", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019003904", 
          "https://doi.org/10.1023/a:1011921122595"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00281-005-0003-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034722638", 
          "https://doi.org/10.1007/s00281-005-0003-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00467-003-1192-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013508805", 
          "https://doi.org/10.1007/s00467-003-1192-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00467-003-1289-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046852974", 
          "https://doi.org/10.1007/s00467-003-1289-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-08-26", 
    "datePublishedReg": "2009-08-26", 
    "description": "The haemolytic uraemic syndrome (HUS) includes the triad of haemolytic anaemia, thrombocytopenia, and acute renal failure. The classical form [D(+) HUS] is caused by infectious agents, and it is a common cause of acute renal failure in children. The enterohaemorrhagic Escherichia coli-producing Shiga toxin (Stx) is the most common infectious agent causing HUS. Other infectious agents are Shigella and Streptococcus pneumoniae. Infections by S. pneumoniae can be particularly severe and has a higher acute mortality and a higher long-term morbidity compared to HUS by Stx. Atypical HUS [D(\u2212)Stx(\u2212)HUS] are often used by paediatricians to indicate a presentation of HUS without preceding diarrhoea. Almost all patients with D(\u2212)Stx(\u2212)HUS have a defect in the alternative pathway, for example, mutations in the genes for complement factor H, factor I, and membrane co-factor protein. Mutations in the factor H gene are described more often. The majority of children with D(+) HUS develop some degree of renal insufficiency, and approximately two thirds of children with HUS will require dialysis therapy, while about one third will have milder renal involvement without the need for dialysis therapy. General management of acute renal failure includes appropriate fluid and electrolyte management, antihypertensive therapy, and the initiation of renal replacement therapy when appropriate. Specific management issues in HUS include management of the haematological complications of HUS, monitoring for extra-renal involvement, avoiding antidiarrhoeal drugs, and possibly avoiding of antibiotic therapy. In addition to the obligatory supportive treatment and tight control of hypertension, there is anecdotal evidence that plasma therapy may induce remission and, in some cases, maintain it. Fresh frozen plasma contains factor H at physiological concentrations. A new therapy for D(\u2212)Stx(\u2212)HUS is a humanised monoclonal antibody (Eculizumab) that blocks complement activity by cleavage of the complement protein C5. It prevents the generation of the inflammatory peptide C5a and the cytotoxic membrane\u2013attack complex C5b-9. We have first positive results, but it is still not approved for HUS.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00431-009-1039-4", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017354", 
        "issn": [
          "0340-6199", 
          "1432-1076"
        ], 
        "name": "European Journal of Pediatrics", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "169"
      }
    ], 
    "keywords": [
      "haemolytic uraemic syndrome", 
      "acute renal failure", 
      "renal failure", 
      "infectious agents", 
      "dialysis therapy", 
      "high long-term morbidity", 
      "membrane co-factor protein", 
      "atypical haemolytic uraemic syndrome", 
      "extra-renal involvement", 
      "long-term morbidity", 
      "renal replacement therapy", 
      "common infectious agents", 
      "humanised monoclonal antibody", 
      "fresh frozen plasma", 
      "high acute mortality", 
      "factor H", 
      "third of children", 
      "milder renal involvement", 
      "complement protein C5", 
      "majority of children", 
      "membrane attack complex C5b-9", 
      "complement factor H", 
      "specific management issues", 
      "factor H gene", 
      "antihypertensive therapy", 
      "antidiarrhoeal drugs", 
      "renal insufficiency", 
      "renal involvement", 
      "haematological complications", 
      "antibiotic therapy", 
      "supportive treatment", 
      "replacement therapy", 
      "uraemic syndrome", 
      "frozen plasma", 
      "common cause", 
      "electrolyte management", 
      "new therapies", 
      "haemolytic anaemia", 
      "S. pneumoniae", 
      "clinical practice", 
      "complement activity", 
      "Streptococcus pneumoniae", 
      "therapy", 
      "protein C5", 
      "Shiga toxin", 
      "factor I", 
      "acute mortality", 
      "monoclonal antibodies", 
      "C5b-9", 
      "physiological concentrations", 
      "positive results", 
      "first positive results", 
      "appropriate fluid", 
      "children", 
      "pneumoniae", 
      "failure", 
      "alternative pathway", 
      "involvement", 
      "agents", 
      "H gene", 
      "third", 
      "general management", 
      "hypertension", 
      "remission", 
      "thrombocytopenia", 
      "morbidity", 
      "complications", 
      "diarrhea", 
      "patients", 
      "anemia", 
      "syndrome", 
      "pediatricians", 
      "insufficiency", 
      "management", 
      "infection", 
      "mortality", 
      "C5a", 
      "mutations", 
      "classical form", 
      "antibodies", 
      "drugs", 
      "tight control", 
      "Shigella", 
      "treatment", 
      "anecdotal evidence", 
      "Stx", 
      "presentation", 
      "cause", 
      "genes", 
      "toxin", 
      "majority", 
      "initiation", 
      "pathway", 
      "evidence", 
      "triad", 
      "control", 
      "plasma", 
      "protein", 
      "cases", 
      "activity", 
      "C5", 
      "defects", 
      "management issues", 
      "fluid", 
      "concentration", 
      "need", 
      "practice", 
      "addition", 
      "degree", 
      "results", 
      "cleavage", 
      "form", 
      "issues", 
      "generation", 
      "example"
    ], 
    "name": "Clinical practice", 
    "pagination": "7-13", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1046286380"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00431-009-1039-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19707787"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00431-009-1039-4", 
      "https://app.dimensions.ai/details/publication/pub.1046286380"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:53", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_480.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00431-009-1039-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00431-009-1039-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00431-009-1039-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00431-009-1039-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00431-009-1039-4'


 

This table displays all metadata directly associated to this object as RDF triples.

266 TRIPLES      21 PREDICATES      159 URIs      139 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00431-009-1039-4 schema:about N198c7e8692a9424c846374980bd02f5a
2 N73530cf0cb634b66b00e2e8562e7101d
3 Na16e5f1d30dc4b47846b9331400b0562
4 Na7742c09c544484fbb584a7c10c9a884
5 Nb0c59841273f48d081e83cf5cc6eff79
6 Nb0f18815a7934369b94876ddf7742a5a
7 Nde662764e75c41ba8380e5c82bc4038d
8 anzsrc-for:11
9 anzsrc-for:1103
10 schema:author N95ee4206a56f479b87f16c7a7cec50aa
11 schema:citation sg:pub.10.1007/s00281-005-0003-2
12 sg:pub.10.1007/s00467-003-1192-3
13 sg:pub.10.1007/s00467-003-1289-8
14 sg:pub.10.1007/s00467-003-1382-z
15 sg:pub.10.1007/s00467-004-1451-y
16 sg:pub.10.1007/s00467-006-0210-7
17 sg:pub.10.1007/s00467-008-0935-6
18 sg:pub.10.1007/s00467-008-0964-1
19 sg:pub.10.1007/s004670050018
20 sg:pub.10.1007/s004670100564
21 sg:pub.10.1007/s150100050040
22 sg:pub.10.1023/a:1011921122595
23 schema:datePublished 2009-08-26
24 schema:datePublishedReg 2009-08-26
25 schema:description The haemolytic uraemic syndrome (HUS) includes the triad of haemolytic anaemia, thrombocytopenia, and acute renal failure. The classical form [D(+) HUS] is caused by infectious agents, and it is a common cause of acute renal failure in children. The enterohaemorrhagic Escherichia coli-producing Shiga toxin (Stx) is the most common infectious agent causing HUS. Other infectious agents are Shigella and Streptococcus pneumoniae. Infections by S. pneumoniae can be particularly severe and has a higher acute mortality and a higher long-term morbidity compared to HUS by Stx. Atypical HUS [D(−)Stx(−)HUS] are often used by paediatricians to indicate a presentation of HUS without preceding diarrhoea. Almost all patients with D(−)Stx(−)HUS have a defect in the alternative pathway, for example, mutations in the genes for complement factor H, factor I, and membrane co-factor protein. Mutations in the factor H gene are described more often. The majority of children with D(+) HUS develop some degree of renal insufficiency, and approximately two thirds of children with HUS will require dialysis therapy, while about one third will have milder renal involvement without the need for dialysis therapy. General management of acute renal failure includes appropriate fluid and electrolyte management, antihypertensive therapy, and the initiation of renal replacement therapy when appropriate. Specific management issues in HUS include management of the haematological complications of HUS, monitoring for extra-renal involvement, avoiding antidiarrhoeal drugs, and possibly avoiding of antibiotic therapy. In addition to the obligatory supportive treatment and tight control of hypertension, there is anecdotal evidence that plasma therapy may induce remission and, in some cases, maintain it. Fresh frozen plasma contains factor H at physiological concentrations. A new therapy for D(−)Stx(−)HUS is a humanised monoclonal antibody (Eculizumab) that blocks complement activity by cleavage of the complement protein C5. It prevents the generation of the inflammatory peptide C5a and the cytotoxic membrane–attack complex C5b-9. We have first positive results, but it is still not approved for HUS.
26 schema:genre article
27 schema:isAccessibleForFree false
28 schema:isPartOf N52bff4fbea97437f96583fa8b055e752
29 N6b949ad3fb054403a60edd40efe5644b
30 sg:journal.1017354
31 schema:keywords C5
32 C5a
33 C5b-9
34 H gene
35 S. pneumoniae
36 Shiga toxin
37 Shigella
38 Streptococcus pneumoniae
39 Stx
40 activity
41 acute mortality
42 acute renal failure
43 addition
44 agents
45 alternative pathway
46 anecdotal evidence
47 anemia
48 antibiotic therapy
49 antibodies
50 antidiarrhoeal drugs
51 antihypertensive therapy
52 appropriate fluid
53 atypical haemolytic uraemic syndrome
54 cases
55 cause
56 children
57 classical form
58 cleavage
59 clinical practice
60 common cause
61 common infectious agents
62 complement activity
63 complement factor H
64 complement protein C5
65 complications
66 concentration
67 control
68 defects
69 degree
70 dialysis therapy
71 diarrhea
72 drugs
73 electrolyte management
74 evidence
75 example
76 extra-renal involvement
77 factor H
78 factor H gene
79 factor I
80 failure
81 first positive results
82 fluid
83 form
84 fresh frozen plasma
85 frozen plasma
86 general management
87 generation
88 genes
89 haematological complications
90 haemolytic anaemia
91 haemolytic uraemic syndrome
92 high acute mortality
93 high long-term morbidity
94 humanised monoclonal antibody
95 hypertension
96 infection
97 infectious agents
98 initiation
99 insufficiency
100 involvement
101 issues
102 long-term morbidity
103 majority
104 majority of children
105 management
106 management issues
107 membrane attack complex C5b-9
108 membrane co-factor protein
109 milder renal involvement
110 monoclonal antibodies
111 morbidity
112 mortality
113 mutations
114 need
115 new therapies
116 pathway
117 patients
118 pediatricians
119 physiological concentrations
120 plasma
121 pneumoniae
122 positive results
123 practice
124 presentation
125 protein
126 protein C5
127 remission
128 renal failure
129 renal insufficiency
130 renal involvement
131 renal replacement therapy
132 replacement therapy
133 results
134 specific management issues
135 supportive treatment
136 syndrome
137 therapy
138 third
139 third of children
140 thrombocytopenia
141 tight control
142 toxin
143 treatment
144 triad
145 uraemic syndrome
146 schema:name Clinical practice
147 schema:pagination 7-13
148 schema:productId N33c3b19b93f54511b45c6e3a1a4f2245
149 N710c6f59386449948b148976529465b5
150 N9fbff95a66264788affcc35d5dfc6e63
151 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046286380
152 https://doi.org/10.1007/s00431-009-1039-4
153 schema:sdDatePublished 2022-09-02T15:53
154 schema:sdLicense https://scigraph.springernature.com/explorer/license/
155 schema:sdPublisher N6a3243dc30a7415aab32b327651ec923
156 schema:url https://doi.org/10.1007/s00431-009-1039-4
157 sgo:license sg:explorer/license/
158 sgo:sdDataset articles
159 rdf:type schema:ScholarlyArticle
160 N198c7e8692a9424c846374980bd02f5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Humans
162 rdf:type schema:DefinedTerm
163 N33c3b19b93f54511b45c6e3a1a4f2245 schema:name pubmed_id
164 schema:value 19707787
165 rdf:type schema:PropertyValue
166 N52bff4fbea97437f96583fa8b055e752 schema:volumeNumber 169
167 rdf:type schema:PublicationVolume
168 N6a3243dc30a7415aab32b327651ec923 schema:name Springer Nature - SN SciGraph project
169 rdf:type schema:Organization
170 N6b949ad3fb054403a60edd40efe5644b schema:issueNumber 1
171 rdf:type schema:PublicationIssue
172 N710c6f59386449948b148976529465b5 schema:name dimensions_id
173 schema:value pub.1046286380
174 rdf:type schema:PropertyValue
175 N73530cf0cb634b66b00e2e8562e7101d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Renal Replacement Therapy
177 rdf:type schema:DefinedTerm
178 N95ee4206a56f479b87f16c7a7cec50aa rdf:first sg:person.01060501551.47
179 rdf:rest Nf8fb64f12b724a52ab34ae5fb3481378
180 N9fbff95a66264788affcc35d5dfc6e63 schema:name doi
181 schema:value 10.1007/s00431-009-1039-4
182 rdf:type schema:PropertyValue
183 Na16e5f1d30dc4b47846b9331400b0562 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Prognosis
185 rdf:type schema:DefinedTerm
186 Na1ca1870e1d847dd8d0156e95c9dfb12 rdf:first sg:person.0672444171.34
187 rdf:rest rdf:nil
188 Na7742c09c544484fbb584a7c10c9a884 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Hemolytic-Uremic Syndrome
190 rdf:type schema:DefinedTerm
191 Nb0c59841273f48d081e83cf5cc6eff79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Acute Kidney Injury
193 rdf:type schema:DefinedTerm
194 Nb0f18815a7934369b94876ddf7742a5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Complement System Proteins
196 rdf:type schema:DefinedTerm
197 Nde662764e75c41ba8380e5c82bc4038d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Child
199 rdf:type schema:DefinedTerm
200 Nf8fb64f12b724a52ab34ae5fb3481378 rdf:first sg:person.01005340007.98
201 rdf:rest Na1ca1870e1d847dd8d0156e95c9dfb12
202 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
203 schema:name Medical and Health Sciences
204 rdf:type schema:DefinedTerm
205 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
206 schema:name Clinical Sciences
207 rdf:type schema:DefinedTerm
208 sg:journal.1017354 schema:issn 0340-6199
209 1432-1076
210 schema:name European Journal of Pediatrics
211 schema:publisher Springer Nature
212 rdf:type schema:Periodical
213 sg:person.01005340007.98 schema:affiliation grid-institutes:grid.5361.1
214 schema:familyName Rosales
215 schema:givenName Alejandra
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005340007.98
217 rdf:type schema:Person
218 sg:person.01060501551.47 schema:affiliation grid-institutes:grid.5361.1
219 schema:familyName Scheiring
220 schema:givenName Johanna
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060501551.47
222 rdf:type schema:Person
223 sg:person.0672444171.34 schema:affiliation grid-institutes:grid.5361.1
224 schema:familyName Zimmerhackl
225 schema:givenName Lothar Bernd
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672444171.34
227 rdf:type schema:Person
228 sg:pub.10.1007/s00281-005-0003-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034722638
229 https://doi.org/10.1007/s00281-005-0003-2
230 rdf:type schema:CreativeWork
231 sg:pub.10.1007/s00467-003-1192-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013508805
232 https://doi.org/10.1007/s00467-003-1192-3
233 rdf:type schema:CreativeWork
234 sg:pub.10.1007/s00467-003-1289-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046852974
235 https://doi.org/10.1007/s00467-003-1289-8
236 rdf:type schema:CreativeWork
237 sg:pub.10.1007/s00467-003-1382-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1050782066
238 https://doi.org/10.1007/s00467-003-1382-z
239 rdf:type schema:CreativeWork
240 sg:pub.10.1007/s00467-004-1451-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1049444325
241 https://doi.org/10.1007/s00467-004-1451-y
242 rdf:type schema:CreativeWork
243 sg:pub.10.1007/s00467-006-0210-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009821667
244 https://doi.org/10.1007/s00467-006-0210-7
245 rdf:type schema:CreativeWork
246 sg:pub.10.1007/s00467-008-0935-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053074373
247 https://doi.org/10.1007/s00467-008-0935-6
248 rdf:type schema:CreativeWork
249 sg:pub.10.1007/s00467-008-0964-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034552033
250 https://doi.org/10.1007/s00467-008-0964-1
251 rdf:type schema:CreativeWork
252 sg:pub.10.1007/s004670050018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000327276
253 https://doi.org/10.1007/s004670050018
254 rdf:type schema:CreativeWork
255 sg:pub.10.1007/s004670100564 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040633100
256 https://doi.org/10.1007/s004670100564
257 rdf:type schema:CreativeWork
258 sg:pub.10.1007/s150100050040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045126273
259 https://doi.org/10.1007/s150100050040
260 rdf:type schema:CreativeWork
261 sg:pub.10.1023/a:1011921122595 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019003904
262 https://doi.org/10.1023/a:1011921122595
263 rdf:type schema:CreativeWork
264 grid-institutes:grid.5361.1 schema:alternateName Department of Paediatrics, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria
265 schema:name Department of Paediatrics, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria
266 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...